Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
University of Jordan Department of Physiology & Biochemishy Pharmacy students 20 1512016 ++++++++++++++++++++++++++++++++++++++++++ Platelets and Hemostasis: Some hemopoietic stem cells differentiate to produce Megakariocytes. From these huge cells that are found in bone marrow, a small part of the membrane containing cytoplasm is bud off to form a platelet (thrombocyte). Each megakariocyte is forming about 1000-3000 platelets. In circulating blood, the average number of thrombocytes is 150.000 - 300.000 /mm3 1pl;. Platelets are functional for about 10 days, then they are removed by macrophages located in spleen and liver. Their normal function is important for the process of hemostasis. Hemostasis: Hemostasis refers to the process that stops bleeding. There are three mechanisms involved in hemostasis: 1. Vascular spasm. 2. Platelets plug formation. 3. Blood clotting (coagulation). 1. Vascular spasm: This represents an immediate response to vascular injury, which appears as a reflex that results in contraction of vascular smooth muscle cells to reduce blood loss. During this mechanism, the other mechanisms of hemostasis are prepared to enter in action to reduce bleeding. 2. Platelets plug formation: under normal conditions, platelets are inactive ceils and having a disc-shape. These cells contain two types of granules: a) Alpha granules: containing some Clotting factors, Platelets Derived growth factor (PDGF) and contractile proteins" b) Dense granules: containing ADp, ATp, Ca*+, serotonin, enzymes that produce thromboxane A, prostaglandins and fibrin stabilizing factor. Plug formation appears in three steps: - platelets tl.o*" in contact with tissues at the level of fibers of damaged vessels. This results is platelets adhesion to collagen conneitive tissue underlying damaged endothelial ceils. - The result of this adhesion is platelets activation. The activated platelets release ADP, thromboxane A2 and serotonin' This phase is known as platelets release reaction. Thromboxane A2 and serotonin can acton blood vessels to maintain the vasoconstriction' - ADP released activates more platelets that become sticky and adhere to other activated platelets forming mass of platelets. This process is called platelets aggregation. The formed mass of platelets is -k ro*, as platelets ptug. This plug is very effective in preventing blood loss in small vessels and becomes more tight when it is reinforced by formation of fibrin thread that appears after blood clotting3. Blood clotting and related mechanisms: - Clot formation: Plasma contains proteins that are capable of forming a gel like structure after being activated. The process of gel formation is called clotting or coagulation. The proteins involved in clotting are known as clotting factors. Plasma without these clotting factors is known as serum. The clot is formed by converting soluble fibrinogen, which is found in blood, into fibrin threads, which is an insoluble product. The process of clot formation appears in many stages and through two different pathways: 1. Extrinsic pathway: in which clot formation appears as a result of activation by a factor released by damaged tissues called thromboplastin. This factor activates a clotting-factor X in the presence of Ca++. 2. Intrinsic pathway: in this pathway, clot formation begins with activation of blood factor XII. As a result of this activation, factor XI and then IX (Christmas factor or antihemophilic factor B) are activated. The activated factor IXwill activate fuctor X in the presence of Ca**, factor VIII (Antihemophilic factor A) and platelets factors (phospholipids released by activated platelets). will form with Caf* and factor V a complex which act as an active eflzyme known as prothrombinase. This enzyme converts prothrombin irfio thrombin, which in turn acts to convert fibriaegen into fibtin. Formation of fibrin is followed by stabilization of fibrin thread by factor XIII (fibrin stabilizing factor). Role of vitamin K in clotting: Normal clotting depends on Vitamin K. Although vitamin K is not involved in any process of clot formation, but this vitamin is required hrombi which i for synthesis of VII. IX and X) b),liver cells. - Clot retraction: After clot formation, platelets are become also in contact with the fibrin thread. This thread is strengthened by stabilization with the help of factor XIII. By the activity of platelets, the formed thread gradually contract (retract) to pull the edges of damaged vessels closer together. After this process, repairing of injury atthatvessel is taking place by proliferation of endothelial cells and other tissues that are forming the vessels. - Fibrinolysis: After the process of formation of fibrin thread and retraction, a process of repair is taking place. This process requires removal of fibrin thread. Another process is taking place is known as fibrinolysis. By this process, fibrinolyic enzyme known as plasmin is involved. Usually this enzyme is found in the blood in an inactive form and known as plasminogen. It is activated by thrombin. active factor XII and tissue plasminogen activator (t-PA). Plasminogen ) t Plasmin ) fibrinolysis. Thrombin, factor XII, tissue plasminogen activators Control mechanisms of hemostasis: The process of platelets aggregation and clot formation are controlled by many mechanisms. Activation of these processes appear after vessel injury or by the presence of roughness at vessel wall after a disease called atherosclerosis. The mechanisms that induce activation of plug formation or clotting are opposed by many factors that prevent blood clotting inside vessels. These factors include: - Prostacyclin opposes platelets adhesion (the action of thromboxane A2). - Antithrombin III: blocks the action of XII, XI, IX, X and IL - Protein c: inactivates factors plasminogen activators. v and VIII. Enhances the activity of Alpha-1- antitrypsin: inhibits factor XI' -Heparin:increaseseffectivenessofantithrombinlll. may result in NOte: any decrease in the activity of factors that inhibit coagulation and block inside vessels)' This thrombus can be taken with blood thrombosis (clot formation the blood flow inside vessels. This is known as embolism' Blood GrouPs and transfusion: and The plasma membrane of red blood cells have glycoproteins giycolipid, ltt ut have antigenic activity) known as agglutinogens. The presence of these agglutinogens on RBCs determine the blood groups - and types: According to agglutinogens A and B: 4 types of blood are known: Type A: in which RBCs have agglutinogens A' Type B: in which RBCs have agglutinogens B' fyp" AB: in which RBCs have agglutinogens A and B' Type O: in which RBCs have NO agglutinogens' In addition to agglutinogens A and/or B, RBCs may have another factor that has antigenic activity known as Rh factor or the D- antigen. The RBCs that have the Rh factor (D-antigen), the type of blood determined is Rh+ (positive (+)) and written as Rh+. When RBCs have NO Rh factor (D-antigen), the type of blood is known as rh- (negative(-)). In these types of blood, plasma may contain antibodies (known as agglutinins) that can react with antigens A, B or D. Under normal conditions, plasma has NO agglutinins that can react with agglutinogens of own RBCs. Ex: Blood type A has NO asglutinins that can react with the agglutinogen A. But this type of blood has agglutinins that can react with agglutinogen B. The agglutinins that can react with B agglutinogens are known as beta agglutinins. Plasma of (B type blood) contains kno agglutinins that can react with A anti agglutinins. Plasma of (O blood type) contains both agglutinins (alpha & beta agglutinins) that can react with both A and B agglutinogens' In plasma of Btood type AB. there are NO aqglutinins that can react with A and lor B agglutinogens. blood:fry,^:l".:::: With regard to persons having Rh.+ positive In rh- (neeative) tvPe. NO antibodies against this factor il'h:i1,plit*1elon if thej Anti-D (anti-Rh) antibo of a mother having . An .aronn hoc heen exnosed "*u-Ple of a babY l1?^":,P"' antibodies if Anti-D deverop io stimulated be can #;;";;;i"* ;., mr I- ,---^ ^tl ^ of r" mothers circulation during delivery' The formation #;dir $1} l':ip *'l r'r* baby because these antibodies in mothers plasma will affect the second factor of the puSS placenta and react with antigens.(Rh+) antibodies "r, second baby. }ris is known as erythroblastosis fetalis. To avoid this situation, Anti-D injection is given to within the first 72 hours after delivery' Blood Transfusion: Knowing blood types is important for blood transfusion' The most his important rulels NOT giving a type of blood to a person who has in ptus*a agglutinins that can react agglutinogens of the blood donor' For that: The o type blood can receive only o type blood, and can give to all groups. - But persons with (AB type) can be recipient from all types (A, B, AB, and O type). For that the AB type is known as general recipient' This type can give blood only to AB group. A type can receive from A and o types, and give to A and AB B type can receive from B and o types, and give to B and AB. With regard to Rh system. Rh+ blood can receive from both Rh+ and rh-, while an rh- (for not giving a chance to have antibodies developed in his plasma) can receive only an rh- (negative) blood' GOOD LUCK GOOD LUCK